FPR1 Rabbit Polyclonal Antibody
cat.: R1511-36
| Product Type: | Rabbit polyclonal IgG, primary antibodies |
|---|---|
| Species reactivity: | Human, Mouse |
| Applications: | WB, IHC-P |
| Clonality: | Polyclonal |
| Form: | Liquid |
| Storage condition: | Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term. |
| Storage buffer: | 1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1ug/ul |
| Purification: | Immunogen affinity purified. |
| Molecular weight: | 38 kDa |
| Isotype: | IgG |
| Immunogen: | Synthetic peptide within Mouse FPR1 aa 151-200 / 364 |
| Positive control: | Mouse spleen, human tonsil tissue, human spleen tissue. |
| Subcellular location: | Cell membrane. |
| Recommended Dilutions:
WB IHC-P |
1:1000 1:50-1:100 |
| Uniprot #: | SwissProt: P21462 Human |
| Alternative names: | fMet Leu Phe receptor fMet-Leu-Phe receptor FMLP fMLP receptor FMLPR Formyl peptide receptor 1 FPR 1 FPR FPR receptor FPR1 FPR1_HUMAN N formyl peptide chemoattractant receptor N formyl peptide receptor N formylpeptide chemoattractant receptor N-formyl peptide receptor N-formylpeptide chemoattractant receptor |
Images
|
Fig1:
Western blot analysis of FPR1 on mouse spleen tissue lysa with Rabbit anti-FPR1 antibody (R1511-36) at 1/1,000 dilution. Lysates/proteins at 10 µg/Lane. Exposure time: 59 seconds; ECL: K1801 Blocking: 5% NFDM/TBST, 1 hour at room temperature Primary antibody: R1511-36, 1/1,000 in 5% NFDM/TBST, 4° overnight Secondary antibody: Goat Anti-Mouse IgG-HRP(HA1006), 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature Predicted band size: 38 kDa Observed band size: 38 kDa |
|
Fig2: Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-FPR1 antibody. Counter stained with hematoxylin. |
|
Fig3: Immunohistochemical analysis of paraffin-embedded human spleen tissue using anti-FPR1 antibody. Counter stained with hematoxylin. |
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.